CO-DIAGNOSTICS, INC. Form 8-K (July 8, 2021)

Summary

Current report on Form 8-K of Co-Diagnostics, Inc. reporting an event dated July 8, 2021. Under Item 5.02, Mr. Reed L. Benson resigned as Corporate Secretary on July 8, 2021, having served in that role since the company's inception in April 2013. The filing states that the resignation was not the result of any disagreement with management or the Board of Directors, and that Mr. Benson will remain an employee in the role of general counsel. The Board of Directors appointed Brian L. Brown, CPA as Corporate Secretary on July 8, 2021, and the filing states that no compensatory plan, contract or arrangement was entered into relating to that appointment. The signature block carries /s/ Dwight H. Egan, Chief Executive Officer, dated July 9, 2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

FORM
8-K

CURRENT
REPORT

Pursuant
to Section 13 or 15(d) of the

Securities
Exchange Act of 1934

Date
of report (Date of earliest event reported): July 8, 2021

CO-DIAGNOSTICS,
INC.

(Exact
name of small business issuer as specified in its charter)

Utah | 1-38148 | 46-2609363
(State
 or other jurisdiction of | (Commission | (IRS
 Employer
incorporation
 or organization) | File
 Number) | Identification
 Number)

2401
S. Foothill Drive, Suite D, Salt Lake City, Utah 84109

(Address
of principal executive offices)

(801)
438-1036

(Issuer’s
telephone number)

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

[
 ] | Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[
 ] | Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[
 ] | Pre-commencement
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[
 ] | Pre-commencement
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities
registered pursuant to Section 12(b) of the Act:

Title
 of each class | Trading
 Symbol(s) | Name
 of each exchange on which registered
Common
 Stock, $0.001 par value | CODX | Nasdaq
 Capital Market

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging
growth company [X]

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
July 8, 2021, Mr. Reed L. Benson resigned as the Corporate Secretary of Co-Diagnostics, Inc., a Utah corporation (the “ Company ”).
Mr. Benson had served as the Company’s Corporate Secretary since its inception in April 2013. Mr. Benson’s resignation as
Corporate Secretary was not the result of any disagreement with the Company’s management or Board of Directors relating to the
Company’s operations, policies, or practices. Mr. Benson will remain an employee of the Company in the role of general counsel.

On
July 8, 2021, the Company’s Board of Directors appointed Brian L. Brown, CPA, as the Company’s Corporate Secretary. As previously
reported in a Form 8-K filed by the Company on February 22, 2021, Mr. Brown was appointed as the Company’s Chief Financial Officer
on February 22, 2021, and will remain in such position.

There
no compensatory plan, contract, or arrangement (whether or not written) entered into between the Company and Mr. Brown relating to his
appointment as Corporate Secretary.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.

CO-DIAGNOSTICS,
 INC.
By: | /s/
 Dwight H. Egan
Name: | Dwight
 H. Egan
Title: | Chief
 Executive Officer

Date:
July 9, 2021

File and source

File

SEC_CODX_8-K_filed2021-07-09_0001493152-21-016480.htm

Size

27,734 bytes

SHA-256

0c61453c5433085cdb3402f1cc5e4d8f25a94dccc0601b45defe34ca9021f4f1

Our copy

SEC_CODX_8-K_filed2021-07-09_0001493152-21-016480.htm

Original

www.sec.gov